The value of 18F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis.

Narjess AyatiRamin SadeghiZahra KiamaneshSze Ting LeeS Rasoul ZakaviAndrew Mark Scott

Published in: European journal of nuclear medicine and molecular imaging (2020)

The baseline SUVpeak, MTV, and TLG parameters represent promising predictors of the final response of metastatic melanoma patients to immunotherapy. Modified response assessment criteria are potentially an appropriate method for monitoring immunotherapy. irAEs are also valuable for predicting eventual clinical benefit of treatment.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
smoking cessation
combination therapy